Meta-analysis of once-daily and twice-daily lopinavir/ritonavir combined with NRTIs in HIV-1-infected, antiretroviral-naive patients

Author： van Wyk Jean   Qaqish Roula   Hollar Kimberly   White Kelly   D’’Amico Ronald   Norton Michael   Chiu Yi-Lin   King Martin  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.7, Iss.1, 2012-01, pp. : 103-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Lopinavir/Ritonavir Compared with Atazanavir in Antiretroviral-Naive Patients: Modelling the Combined Effects of HIV and Heart Disease

By Simpson Kit N.  

Clinical Drug Investigation, Vol. 27, Iss. 1, 2007-01 ,pp. : 67-74

Adis International

Access to resources Recommend Favorite

Model‐Based Once‐Daily Darunavir/Ritonavir Dosing Recommendations in Pediatric HIV‐1‐Infected Patients Aged ≥3 to

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 7, 2015-08 ,pp. : 406-414

John Wiley & Sons Inc

Access to resources Recommend Favorite

Once-daily carmoterol challenges twice-daily formoterol in asthma

By  

Inpharma, Vol. 1, Iss. 1562, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Once-daily ciclesonide equals twice-daily fluticasone for asthma

By  

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Neratinib once-daily and twice-daily dosages are comparable for onset of diarrhoea

By  

Reactions Weekly, Vol. 1, Iss. 1334, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite